Vaccine maker $NVAX-2.7% Novavax plans to reduce its total global workforce by about 12% to cut costs. Given the reported results, I understand the move, and I wonder if it will help them dig out of the red when the approval of a new covid vaccine didn't.
One of the fastest growing investor communities in Europe
Comprehensive data and information on thousands of stocks from around the world
Current information from global markets and individual companies
Education and exchange of investment experience among investors
Fair prices, portfolio tracker, stock screener and other tools
All data provided on Bulios is provided for informational purposes only, and is not intended for trading or investing purposes. Find out more
© Bulios 2024
I also read this somewhere and it's good news, I'm still holding them but it's a big misery and Covid is passé already, I hope they somehow mobilize and come up with something to bounce back on, otherwise I think they're going to declare bankruptcy.